The last time I wrote about 4D Molecular Therapeutics, Inc. (FDMT), it was in a Seeking Alpha article entitled “4d Molecular Therapeutics: Several Value Inflection Points To Watch In 2024.” In this ...
4D Molecular Therapeutics (FDMT) has several clinical programs in its pipeline, with one of them being 4D-710 being advanced for the treatment of patients with Cystic Fibrosis [CF]. The most recent ...